1. Home
  2. LINC vs CSTL Comparison

LINC vs CSTL Comparison

Compare LINC & CSTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lincoln Educational Services Corporation

LINC

Lincoln Educational Services Corporation

HOLD

Current Price

$22.65

Market Cap

732.0M

Sector

Real Estate

ML Signal

HOLD

Logo Castle Biosciences Inc.

CSTL

Castle Biosciences Inc.

HOLD

Current Price

$39.62

Market Cap

661.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LINC
CSTL
Founded
1946
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Medical Specialities
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
732.0M
661.7M
IPO Year
2005
2019

Fundamental Metrics

Financial Performance
Metric
LINC
CSTL
Price
$22.65
$39.62
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
6
Target Price
$26.67
$38.67
AVG Volume (30 Days)
262.8K
431.2K
Earning Date
11-10-2025
11-03-2025
Dividend Yield
N/A
N/A
EPS Growth
40.12
N/A
EPS
0.45
N/A
Revenue
$494,742,000.00
$343,530,000.00
Revenue This Year
$17.79
N/A
Revenue Next Year
$9.23
N/A
P/E Ratio
$50.41
N/A
Revenue Growth
16.90
10.15
52 Week Low
$14.10
$14.59
52 Week High
$25.76
$40.61

Technical Indicators

Market Signals
Indicator
LINC
CSTL
Relative Strength Index (RSI) 62.20 78.85
Support Level $20.25 $38.69
Resistance Level $20.89 $40.61
Average True Range (ATR) 0.97 1.53
MACD 0.29 -0.05
Stochastic Oscillator 96.53 86.08

Price Performance

Historical Comparison
LINC
CSTL

About LINC Lincoln Educational Services Corporation

Lincoln Educational Services Corp provides diversified career-oriented post-secondary education to high school graduates and working adults. The company offers programs in automotive technology, skilled trades, healthcare services, hospitality services, and business and information technology. Its reportable segments include; Campus Operations, and Transitional. The majority of the revenue is generated from the Campus Operations segment which includes all campuses that are continuing in operation and contribute to the Company's core operations and performance.

About CSTL Castle Biosciences Inc.

Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. It also provides DecisionDx-UM, a risk stratification GEP test. The company also offers its products to the skin cancer and gastroenterology markets.

Share on Social Networks: